用于调节抗瘤免疫力的纳米催化剂:制造,机制和应用
Xianbo Wu1, Yuqing Li1, Mei Wen1
1Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan 410083, China. chenws@csu.edu.cn.
Chemical Society reviews
|February 5, 2024
概括
催化纳米药物通过将瘤物质转化为治疗产品来增强癌症免疫疗法. 这种方法同时根除瘤并调节免疫系统,改善全身抗瘤免疫力.
科学领域:
- 纳米技术和催化化学
- 免疫学和瘤学
背景情况:
- 免疫疗法是一种有前途的癌症治疗方法,但瘤免疫抑制限制了它的有效性.
- 催化纳米药物提供了一种新的方法,通过利用瘤微环境中的催化反应来克服这些限制.
研究的目的:
- 审查催化纳米药物的制造,结构和工程策略.
- 讨论催化基质和纳米催化剂在癌症免疫治疗中的应用.
- 阐明纳米结构与免疫调节性能之间的关系,以更深入地了解它们的机制.
主要方法:
- 探索各种催化纳米医学平台,包括纳米酶,光催化剂,声催化剂,芬顿催化剂,电催化剂,压催化剂,热催化剂和放射催化剂.
- 在现场分析催化基质及其转化为治疗产品的分析.
- 讨论结构-活动关系和优化纳米医药性能的工程策略.
主要成果:
- 催化纳米药可以同时实现瘤根除和免疫调节.
- 不同的催化纳米医学类型在癌症免疫治疗中显示出广泛的应用.
- 了解纳米结构和免疫反应之间的相互作用对于治疗疗效至关重要.
结论:
- 催化纳米药物代表了癌症免疫疗法的重大进步.
- 对纳米催化剂开发及其机制的进一步研究对未来的癌症治疗策略有希望.
- 这篇评论强调了纳米催化剂在克服瘤免疫抑制和增强全身抗瘤免疫力的潜力.
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
917
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
917


